NCT02059265 · Interventional trial
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer
Overall registry status Terminated
Phase 2
Conditions Endometrial Clear Cell Adenocarcinoma, Ovarian Clear Cell Cystadenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Recurrent Uterine Corpus Cancer
Delaware Valley sites
- Jefferson Abington Hospital · Abington, PA · Montgomery County
First posted
Registry updated
Added to the directory